Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 469

1.

Antidepressant effect of the translocator protein antagonist ONO-2952 on mouse behaviors under chronic social defeat stress.

Nozaki K, Ito H, Ohgidani M, Yamawaki Y, Sahin EH, Kitajima T, Katsumata S, Yamawaki S, Kato TA, Aizawa H.

Neuropharmacology. 2019 Nov 1:107835. doi: 10.1016/j.neuropharm.2019.107835. [Epub ahead of print]

PMID:
31682855
2.

Phospholipase C-related catalytically inactive protein regulates lipopolysaccharide-induced hypothalamic inflammation-mediated anorexia in mice.

Yamawaki Y, Shirawachi S, Mizokami A, Nozaki K, Ito H, Asano S, Oue K, Aizawa H, Yamawaki S, Hirata M, Kanematsu T.

Neurochem Int. 2019 Dec;131:104563. doi: 10.1016/j.neuint.2019.104563. Epub 2019 Oct 4.

3.

Predicting Ventral Striatal Activation During Reward Anticipation From Functional Connectivity at Rest.

Mori A, Klöbl M, Okada G, Reed MB, Takamura M, Michenthaler P, Takagaki K, Handschuh PA, Yokoyama S, Murgas M, Ichikawa N, Gryglewski G, Shibasaki C, Spies M, Yoshino A, Hahn A, Okamoto Y, Lanzenberger R, Yamawaki S, Kasper S.

Front Hum Neurosci. 2019 Aug 27;13:289. doi: 10.3389/fnhum.2019.00289. eCollection 2019.

4.

Controlled emotional tactile stimulation during functional magnetic resonance imaging and electroencephalography.

Kanayama N, Hara M, Watanabe J, Kitada R, Sakamoto M, Yamawaki S.

J Neurosci Methods. 2019 Nov 1;327:108393. doi: 10.1016/j.jneumeth.2019.108393. Epub 2019 Aug 12.

PMID:
31415843
5.

Alcohol Use Disorders Identification Test-consumption Predicts the Risk of Excessive Alcohol Consumption After Liver Transplantation.

Yano T, Ohira M, Sakamoto R, Narisada A, Shimizu S, Tahara H, Ide K, Kobayashi T, Imamura M, Machino A, Yamawaki S, Chayama K, Ohdan H.

Transplant Proc. 2019 Jul - Aug;51(6):1934-1938. doi: 10.1016/j.transproceed.2019.02.031.

PMID:
31399178
6.

Reliability and Validity of the Children's Depression Inventory Japanese Version.

Ozono S, Nagamitsu SI, Matsuishi T, Yamashita Y, Ogata A, Suzuki SI, Mashida N, Koseki S, Sato H, Ishikawa SI, Togasaki Y, Sato Y, Sato S, Sasaki K, Shimada H, Yamawaki S.

Pediatr Int. 2019 Jul 25. doi: 10.1111/ped.13984. [Epub ahead of print]

PMID:
31344290
7.

An exacerbation of severe asthma with fungal sensitization successfully treated with voriconazole via a reduction of the fungal burden.

Katsube O, Kono Y, Tsuzuki R, Yamawaki S, Soeda S, To M, To Y.

Allergol Int. 2019 Oct;68(4):549-551. doi: 10.1016/j.alit.2019.05.007. Epub 2019 Jun 21. No abstract available.

8.

Role of coping with negative emotions in cognitive behavioral therapy for persistent somatoform pain disorder: Is it more important than pain catastrophizing?

Yoshino A, Okamoto Y, Jinnin R, Takagaki K, Mori A, Yamawaki S.

Psychiatry Clin Neurosci. 2019 Sep;73(9):560-565. doi: 10.1111/pcn.12866. Epub 2019 Jun 13.

PMID:
31102312
9.

Simple chest closure of open window thoracostomy for postpneumonectomy empyema: a case report.

Fukui T, Matsukura T, Wakatsuki Y, Yamawaki S.

Surg Case Rep. 2019 Apr 5;5(1):53. doi: 10.1186/s40792-019-0612-y.

10.

A difference in the effects of a comorbidity of allergic rhinitis on asthma symptoms between obese and non-obese patients.

To M, Tsuzuki R, Katsube O, Yamawaki S, Soeda S, Kono Y, Honda N, Kano I, Haruki K, To Y.

Respir Investig. 2019 May;57(3):286-289. doi: 10.1016/j.resinv.2019.02.006. Epub 2019 Mar 27. No abstract available.

PMID:
30926236
11.

Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials.

Noma H, Furukawa TA, Maruo K, Imai H, Shinohara K, Tanaka S, Ikeda K, Yamawaki S, Cipriani A.

J Affect Disord. 2019 May 1;250:419-424. doi: 10.1016/j.jad.2019.03.031. Epub 2019 Mar 6.

PMID:
30878654
12.

Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder.

Itagaki K, Takebayashi M, Abe H, Shibasaki C, Kajitani N, Okada-Tsuchioka M, Hattori K, Yoshida S, Kunugi H, Yamawaki S.

Int J Neuropsychopharmacol. 2019 Apr 1;22(4):261-269. doi: 10.1093/ijnp/pyz005.

13.

Case series of allergic bronchopulmonary aspergillosis treated successfully and safely with long-term mepolizumab.

Soeda S, To M, Kono Y, Yamawaki S, Tsuzuki R, Katsube O, Watanabe N, To Y.

Allergol Int. 2019 Jul;68(3):377-379. doi: 10.1016/j.alit.2018.12.008. Epub 2019 Jan 28. No abstract available.

14.

Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: a pooled analysis of individual patient data.

Shinohara K, Tanaka S, Imai H, Noma H, Maruo K, Cipriani A, Yamawaki S, Furukawa TA.

Evid Based Ment Health. 2019 Feb;22(1):10-16. doi: 10.1136/ebmental-2018-300073. Epub 2019 Jan 21.

PMID:
30665989
15.

Altered Gamma-Band Activity as a Potential Biomarker for the Recurrence of Major Depressive Disorder.

Yamamoto T, Sugaya N, Siegle GJ, Kumano H, Shimada H, Machado S, Murillo-Rodriguez E, Rocha NB, Nardi AE, Takamura M, Okamoto Y, Yamawaki S.

Front Psychiatry. 2018 Dec 12;9:691. doi: 10.3389/fpsyt.2018.00691. eCollection 2018.

16.

Allergic bronchopulmonary aspergillosis successfully treated with benralizumab.

Soeda S, Kono Y, Tsuzuki R, Yamawaki S, Katsube O, To M, To Y.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1633-1635. doi: 10.1016/j.jaip.2018.11.024. Epub 2018 Dec 1. No abstract available.

PMID:
30513359
17.

Towards Objective Olfactory Evaluation Based On Peripheral Arterial Stiffness And Heart Rate Variability Indices.

Totsuka M, Soh Z, Sasaoka T, Yamawaki S, Tsuji T.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:5618-5623. doi: 10.1109/EMBC.2018.8513577.

PMID:
30441610
18.

Enduring effects of a 5-week behavioral activation program for subthreshold depression among late adolescents: an exploratory randomized controlled trial.

Takagaki K, Okamoto Y, Jinnin R, Mori A, Nishiyama Y, Yamamura T, Yokoyama S, Shiota S, Okamoto Y, Miyake Y, Ogata A, Kunisato Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S.

Neuropsychiatr Dis Treat. 2018 Oct 9;14:2633-2641. doi: 10.2147/NDT.S172385. eCollection 2018.

19.

Identification of depression subtypes and relevant brain regions using a data-driven approach.

Tokuda T, Yoshimoto J, Shimizu Y, Okada G, Takamura M, Okamoto Y, Yamawaki S, Doya K.

Sci Rep. 2018 Sep 20;8(1):14082. doi: 10.1038/s41598-018-32521-z.

20.

Effects of behavioral activation program without psychotropic medication treatment for depression in late adolescence: case report.

Takagaki K, Okamoto Y, Jinnin R, Yokoyama S, Yoshino A, Kagawa F, Okamoto Y, Miyake Y, Yamawaki S.

Neuropsychiatr Dis Treat. 2018 Aug 27;14:2159-2164. doi: 10.2147/NDT.S168077. eCollection 2018.

21.

A case of chronic eosinophilic pneumonia successfully treated with mepolizumab.

To M, Kono Y, Yamawaki S, Soeda S, Katsube O, Kishi H, To Y.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1746-1748.e1. doi: 10.1016/j.jaip.2018.06.017. Epub 2018 Jul 7. No abstract available.

PMID:
30201098
22.

[The Role of the Habenula in Depression: A Review of the Human fMRI Studies].

Yoshino A, Aizawa H, Takamura M, Ichikawa N, Shibasaki C, Yamawaki Y, Sasaoka T, Okamoto Y, Yamawaki S.

Brain Nerve. 2018 Sep;70(9):1017-1023. doi: 10.11477/mf.1416201121. Review. Japanese.

PMID:
30177579
23.

Effects of behavioural activation on the neural circuit related to intrinsic motivation.

Mori A, Okamoto Y, Okada G, Takagaki K, Takamura M, Jinnin R, Ichikawa N, Yamamura T, Yokoyama S, Shiota S, Yoshino A, Miyake Y, Okamoto Y, Matsumoto M, Matsumoto K, Yamawaki S.

BJPsych Open. 2018 Sep;4(5):317-323. doi: 10.1192/bjo.2018.40.

24.

HtrA1 Is Specifically Up-Regulated in Active Keloid Lesions and Stimulates Keloid Development.

Yamawaki S, Naitoh M, Kubota H, Aya R, Katayama Y, Ishiko T, Tamura T, Yoshikawa K, Enoshiri T, Ikeda M, Suzuki S.

Int J Mol Sci. 2018 Apr 24;19(5). pii: E1275. doi: 10.3390/ijms19051275.

25.

Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta-analysis.

Furukawa TA, Maruo K, Noma H, Tanaka S, Imai H, Shinohara K, Ikeda K, Yamawaki S, Levine SZ, Goldberg Y, Leucht S, Cipriani A.

Acta Psychiatr Scand. 2018 Jun;137(6):450-458. doi: 10.1111/acps.12886. Epub 2018 Apr 3.

PMID:
29611870
26.

Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial.

Nakashima K, Aoshima M, Ohfuji S, Yamawaki S, Nemoto M, Hasegawa S, Noma S, Misawa M, Hosokawa N, Yaegashi M, Otsuka Y.

Hum Vaccin Immunother. 2018;14(8):1923-1930. doi: 10.1080/21645515.2018.1455476. Epub 2018 May 14.

27.

Affective auditory stimulus database: An expanded version of the International Affective Digitized Sounds (IADS-E).

Yang W, Makita K, Nakao T, Kanayama N, Machizawa MG, Sasaoka T, Sugata A, Kobayashi R, Hiramoto R, Yamawaki S, Iwanaga M, Miyatani M.

Behav Res Methods. 2018 Aug;50(4):1415-1429. doi: 10.3758/s13428-018-1027-6.

PMID:
29520632
28.

Quantitative Evaluation of Pain during Electrocutaneous Stimulation using a Log-Linearized Peripheral Arterial Viscoelastic Model.

Matsubara H, Hirano H, Hirano H, Soh Z, Nakamura R, Saeki N, Kawamoto M, Yoshizumi M, Yoshino A, Sasaoka T, Yamawaki S, Tsuji T.

Sci Rep. 2018 Feb 15;8(1):3091. doi: 10.1038/s41598-018-21223-1.

29.

Differential effects of chronic stress in young-adult and old female mice: cognitive-behavioral manifestations and neurobiological correlates.

Lotan A, Lifschytz T, Wolf G, Keller S, Ben-Ari H, Tatarsky P, Pillar N, Oved K, Sharabany J, Merzel TK, Matsumoto T, Yamawaki Y, Mernick B, Avidan E, Yamawaki S, Weller A, Shomron N, Lerer B.

Mol Psychiatry. 2018 Jun;23(6):1432-1445. doi: 10.1038/mp.2017.237. Epub 2017 Dec 19.

PMID:
29257131
30.

Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice.

Yamawaki Y, Yoshioka N, Nozaki K, Ito H, Oda K, Harada K, Shirawachi S, Asano S, Aizawa H, Yamawaki S, Kanematsu T, Akagi H.

Brain Res. 2018 Feb 1;1680:13-38. doi: 10.1016/j.brainres.2017.12.004. Epub 2017 Dec 8.

PMID:
29229502
31.

Distinctive Neuroanatomical Substrates for Depression in Bipolar Disorder versus Major Depressive Disorder.

Matsuo K, Harada K, Fujita Y, Okamoto Y, Ota M, Narita H, Mwangi B, Gutierrez CA, Okada G, Takamura M, Yamagata H, Kusumi I, Kunugi H, Inoue T, Soares JC, Yamawaki S, Watanabe Y.

Cereb Cortex. 2019 Jan 1;29(1):202-214. doi: 10.1093/cercor/bhx319.

PMID:
29202177
32.

Functional Alterations of Postcentral Gyrus Modulated by Angry Facial Expressions during Intraoral Tactile Stimuli in Patients with Burning Mouth Syndrome: A Functional Magnetic Resonance Imaging Study.

Yoshino A, Okamoto Y, Doi M, Okada G, Takamura M, Ichikawa N, Yamawaki S.

Front Psychiatry. 2017 Nov 6;8:224. doi: 10.3389/fpsyt.2017.00224. eCollection 2017.

33.

Effects of behavioral activation on default mode network connectivity in subthreshold depression: A preliminary resting-state fMRI study.

Yokoyama S, Okamoto Y, Takagaki K, Okada G, Takamura M, Mori A, Shiota S, Ichikawa N, Jinnin R, Yamawaki S.

J Affect Disord. 2018 Feb;227:156-163. doi: 10.1016/j.jad.2017.10.021. Epub 2017 Oct 7.

PMID:
29065364
34.

Multiple co-clustering based on nonparametric mixture models with heterogeneous marginal distributions.

Tokuda T, Yoshimoto J, Shimizu Y, Okada G, Takamura M, Okamoto Y, Yamawaki S, Doya K.

PLoS One. 2017 Oct 19;12(10):e0186566. doi: 10.1371/journal.pone.0186566. eCollection 2017.

35.

Predictors of negative symptoms in the chronic phase of schizophrenia: A cross-sectional study.

Fujimaki K, Toki S, Yamashita H, Oyamada T, Yamawaki S.

Psychiatry Res. 2018 Apr;262:600-608. doi: 10.1016/j.psychres.2017.09.051. Epub 2017 Sep 24.

PMID:
28965809
36.

Changes in resting-state brain networks after cognitive-behavioral therapy for chronic pain.

Yoshino A, Okamoto Y, Okada G, Takamura M, Ichikawa N, Shibasaki C, Yokoyama S, Doi M, Jinnin R, Yamashita H, Horikoshi M, Yamawaki S.

Psychol Med. 2018 May;48(7):1148-1156. doi: 10.1017/S0033291717002598. Epub 2017 Sep 12.

PMID:
28893330
37.

Patients with major depressive disorder exhibit reduced reward size coding in the striatum.

Takamura M, Okamoto Y, Okada G, Toki S, Yamamoto T, Ichikawa N, Mori A, Minagawa H, Takaishi Y, Fujii Y, Kaichi Y, Akiyama Y, Awai K, Yamawaki S.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):317-323. doi: 10.1016/j.pnpbp.2017.07.006. Epub 2017 Jul 11.

38.

Prediction of clinical depression scores and detection of changes in whole-brain using resting-state functional MRI data with partial least squares regression.

Yoshida K, Shimizu Y, Yoshimoto J, Takamura M, Okada G, Okamoto Y, Yamawaki S, Doya K.

PLoS One. 2017 Jul 12;12(7):e0179638. doi: 10.1371/journal.pone.0179638. eCollection 2017.

39.

BDNF as a possible modulator of EEG oscillatory response at the parietal cortex during visuo-tactile integration processes using a rubber hand.

Hiramoto R, Kanayama N, Nakao T, Matsumoto T, Konishi H, Sakurai S, Okada G, Okamoto Y, Yamawaki S.

Neurosci Res. 2017 Nov;124:16-24. doi: 10.1016/j.neures.2017.05.006. Epub 2017 Jun 28.

PMID:
28668502
40.

The neural correlates of the metacognitive function of other perspective: a multiple regression analysis study.

Shiota S, Okamoto Y, Okada G, Takagaki K, Takamura M, Mori A, Yokoyama S, Nishiyama Y, Jinnin R, Hashimoto R, Yamawaki S.

Neuroreport. 2017 Aug 2;28(11):671-676. doi: 10.1097/WNR.0000000000000818.

41.

Regional brain functions in the resting state indicative of potential differences between depression and chronic pain.

Yoshino A, Okamoto Y, Doi M, Otsuru N, Okada G, Takamura M, Ichikawa N, Yokoyama S, Yamashita H, Yamawaki S.

Sci Rep. 2017 Jun 7;7(1):3003. doi: 10.1038/s41598-017-03522-1.

42.

Subjectivity of the Anomalous Sense of Self Is Represented in Gray Matter Volume in the Brain.

Kanayama N, Asai T, Nakao T, Makita K, Kozuma R, Uyama T, Yamane T, Kadota H, Yamawaki S.

Front Hum Neurosci. 2017 May 9;11:232. doi: 10.3389/fnhum.2017.00232. eCollection 2017.

43.

Increased amygdala reactivity following early life stress: a potential resilience enhancer role.

Yamamoto T, Toki S, Siegle GJ, Takamura M, Takaishi Y, Yoshimura S, Okada G, Matsumoto T, Nakao T, Muranaka H, Kaseda Y, Murakami T, Okamoto Y, Yamawaki S.

BMC Psychiatry. 2017 Jan 18;17(1):27. doi: 10.1186/s12888-017-1201-x.

44.

β-Adrenergic Receptor Blockers Reduce the Occurrence of Keloids and Hypertrophic Scars after Cardiac Device Implantation: A Single-Institution Case-Control Study.

Enoshiri T, Naitoh M, Yamawaki S, Kawaguchi A, Aya R, Noda K, Katayama Y, Doi T, Kawaji T, Suzuki S.

Plast Reconstr Surg. 2017 May;139(5):1248-1256. doi: 10.1097/PRS.0000000000003239.

PMID:
28092339
45.

Detailed course of depressive symptoms and risk for developing depression in late adolescents with subthreshold depression: a cohort study.

Jinnin R, Okamoto Y, Takagaki K, Nishiyama Y, Yamamura T, Okamoto Y, Miyake Y, Takebayashi Y, Tanaka K, Sugiura Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S.

Neuropsychiatr Dis Treat. 2016 Dec 22;13:25-33. doi: 10.2147/NDT.S117846. eCollection 2017.

46.

Disrupted Brain Activation and Deactivation Pattern during Semantic Verbal Fluency Task in Patients with Major Depression.

Takamura M, Okamoto Y, Okada G, Toki S, Yamamoto T, Yamamoto O, Jitsuiki H, Yokota N, Tamura T, Kurata A, Kaichi Y, Akiyama Y, Awai K, Yamawaki S.

Neuropsychobiology. 2016;74(2):69-77. doi: 10.1159/000453399. Epub 2017 Jan 5.

PMID:
28052303
47.

Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report.

Suhara T, Chaki S, Kimura H, Furusawa M, Matsumoto M, Ogura H, Negishi T, Saijo T, Higuchi M, Omura T, Watanabe R, Miyoshi S, Nakatani N, Yamamoto N, Liou SY, Takado Y, Maeda J, Okamoto Y, Okubo Y, Yamada M, Ito H, Walton NM, Yamawaki S.

Int J Neuropsychopharmacol. 2017 Apr 1;20(4):285-294. doi: 10.1093/ijnp/pyw111. Review.

48.

Corrigendum to "Behavioral activation can normalize neural hypoactivation in subthreshold depression during a monetary incentive delay task" [J. Affect. Disord. 189 (2016) 254-262].

Mori A, Okamoto Y, Okada G, Takagaki K, Jinnin R, Takamura M, Kobayakawa M, Yamawaki S.

J Affect Disord. 2017 Jan 15;208:670. doi: 10.1016/j.jad.2015.12.023. Epub 2015 Dec 19. No abstract available.

PMID:
27955756
49.

Effects of behavioural activation on the neural basis of other perspective self-referential processing in subthreshold depression: a functional magnetic resonance imaging study.

Shiota S, Okamoto Y, Okada G, Takagaki K, Takamura M, Mori A, Yokoyama S, Nishiyama Y, Jinnin R, Hashimoto RI, Yamawaki S.

Psychol Med. 2017 Apr;47(5):877-888. doi: 10.1017/S0033291716002956. Epub 2016 Nov 29.

50.

Cognitive behavioral therapy changes functional connectivity between medial prefrontal and anterior cingulate cortices.

Yoshimura S, Okamoto Y, Matsunaga M, Onoda K, Okada G, Kunisato Y, Yoshino A, Ueda K, Suzuki SI, Yamawaki S.

J Affect Disord. 2017 Jan 15;208:610-614. doi: 10.1016/j.jad.2016.10.017. Epub 2016 Oct 19.

PMID:
27810274

Supplemental Content

Loading ...
Support Center